Street smarts: Ventech returns with event focused on AI agents
Ventech, the premier hub for business and technology innovation in the Central Coast region, will host an event titled “The Future of Work: Humans + AI Agents” on Oct. 21 at the Cabrillo Pavilion in Santa Barbara. The event begins at 5:30 p.m. The talk will explore how a new generation of AI agents can Read More →
805 law: T.O. employment law firm proud of its first year
Thousand Oaks-based EmployLaw Group recently celebrated its one-year anniversary. Co-founders Jamie N. Stein and Ryan Haws say their exclusively employer-side employment law firm educates California employers and protects them before, during and after employment disputes. “Reaching our one-year anniversary is a big source of pride for Ryan and me,” Stein told the Business Times. “We worked really hard to Read More →
Report: Aerospace employs 80,000 in tri-county region
A new report makes the case that with 7,000 companies employing some 80,000 workers, the region should be recognized as a major hub for aerospace and autonomous systems. Called “The Central Coast: Built to Prove What’s Next,” the report catalogues a number of familiar assets and some new initiatives. The report was released by a Read More →

CRE: Colliers expands Santa Barbara presence with new office
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
UMB Bank names new market president for California
UMB Bank, a subsidiary of UMB Financial Corporation, announced Allan Cellini as market president for California on Oct. 13. Since joining UMB, Cellini has played a pivotal leadership role in growing the bank’s presence in the Central Valley, according to the press release. Prior to joining UMB, Cellini served as managing director for BMO and Read More →
Rona inks deal worth up to $1.16B to license obesity drug
Rona Therapeutics, a world-leading RNAi therapeutics company dedicated to addressing cardiometabolic, obesity and degenerative diseases with a next-generation RNA technology platform, announced it has entered into an exclusive worldwide licensing agreement worth up to $1.16 billion with Roche for its investigational obesity drug candidate. Rona is based in Shanghai, China, but maintains a U.S. headquarters Read More →







